Pathstone Holdings, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 2011612 ENGLEWOOD, NJ

Position in REGN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$8,620,440

-$3,673,806 QoQ

Shares Held

13,825

-13.1% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#316

of 1,322 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 67% Shared 0% None 33%

Healthcare · as of Jun 30, 2026

Pathstone Holdings, LLC holds $101,065,916 across 56 Biotechnology names. REGN ranks #2 (8.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	45,952	$22,825,735
2	REGN	Regeneron Pharmaceuticals, Inc. This page	13,825	$8,620,440
3	ASND	Ascendis Pharma A/S	20,248	$5,400,545
4	CYTK	Cytokinetics Inc	47,633	$4,057,854
5	JAZZ	Jazz Pharmaceuticals plc	15,152	$3,651,176
6	PTGX	Protagonist Therapeutics, Inc	28,187	$3,455,162
7	RPRX	Royalty Pharma plc	54,725	$3,068,429
8	ARGX	Argenx SE	3,094	$2,870,519

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,620,440	13,825	-13.1%	Shares	Defined	2026-08-13
2026-03-31	$12,294,246	15,912	+6.6%	Shares	Other	2026-05-11
2025-12-31	$11,519,387	14,924	+18.1%	Shares	Sole	2026-02-13
2025-09-30	$7,107,091	12,640	+19.9%	Shares	Other	2025-11-13
2025-06-30	$5,535,075	10,543	-44.9%	Shares	Other	2025-08-12
2025-03-31	$12,137,892	19,138	+39.9%	Shares	Sole	2025-05-15
2024-12-31	$9,742,536	13,677	-8.4%	Shares	Other	2025-02-14
2024-09-30	$15,696,063	14,931	+0.4%	Shares	Other	2024-11-07
2024-06-30	$15,624,610	14,866	+0.3%	Shares	Sole	2024-08-14
2024-03-31	$14,269,876	14,826	+42.5%	Shares	Defined	2024-05-13
2023-12-31	$9,140,363	10,407	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.